About DiA Imaging Analysis Ltd
DiA Imaging Analysis Ltd is a leading global provider of artificial intelligence-powered ultrasound analysis software specializing in cardiac imaging. The company develops advanced AI-based algorithms that automate the evaluation of cardiac ultrasound images, addressing the traditional challenges of manual interpretation and reader variability. Their flagship product, LVivo Seamless, is an FDA-cleared and CE-marked solution that integrates into echocardiography lab workflows to automatically select and analyze optimal cardiac images, generating key clinical indications of both left and right ventricle function. The software is designed to improve efficiency of routine tasks and effectiveness of workflow in echo lab reading environments. DiA's technology has been clinically validated, including a Mount Sinai study that found their cardiac ultrasound AI algorithm comparable to cardiac MRI. The company serves echocardiologists, sonographers, and imaging specialists globally through partnerships with major healthcare technology companies and imaging solution providers. DiA is an IBM Alpha Zone Accelerator Alumni Startup and has established collaborations with industry leaders including IBM Watson Health, Change Healthcare, ScImage, Circle Cardiovascular Imaging, Konica Minolta Healthcare, and Terason. The company's mission is to make AI-based software accessible to clinicians worldwide by integrating it seamlessly into their daily routines and readflow, ultimately improving patient outcomes and care quality.
Mission & Story
Mission
For artificial intelligence to be truly valuable, it must be integrated into the clinician's daily routine and readflow
Founding Story
DiA Imaging Analysis is an IBM Alpha Zone Accelerator Alumni Startup. Co-founder and CEO Hila Goldman Aslan leads the company's mission to make AI-based software accessible to echocardiologists and sonographers around the world.
Clinical Focus
Medical conditions and clinical areas addressed by DiA Imaging Analysis Ltd.
Who It Serves
Milestones & Awards
Recent Milestones
Partnership with ScImage (June 2022), multi-year agreement with Change Healthcare (March 2022), Mount Sinai clinical validation study (December 2021), partnership with Circle Cardiovascular Imaging (June 2021), integration with Konica Minolta Exa Cardio PACS (November 2020), government grant for COVID-19 ultrasound AI access (May 2020), IBM Watson Health collaboration (December 2019), Terason partnership (August 2019)
Awards & Recognition
IBM Alpha Zone Accelerator Alumni Startup
Key Partnerships
Company Details
- Headquarters
- Be'er Sheva, Israel
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.